ProfileGDS4718 / 232014_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 39% 68% 30% 36% 65% 62% 41% 37% 44% 42% 35% 49% 71% 55% 47% 53% 56% 68% 48% 32% 42% 49% 45% 38% 40% 48% 57% 43% 62% 59% 70% 37% 38% 54% 60% 55% 44% 42% 70% 42% 50% 62% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2823546
GSM549102patient 115, normal, homogenized [OPG study]4.9615939
GSM549104patient 119, normal, homogenized [OPG study]6.7531468
GSM549108patient 138, normal, homogenized [OPG study]4.6056930
GSM549119patient 077, normal, homogenized [OPG study]4.8169636
GSM549133patient 032, cancer, homogenized [OPG study]6.4589965
GSM549139patient 042, cancer, homogenized [OPG study]6.2660762
GSM549099patient 107, normal, homogenized [OPG study]5.0505941
GSM549109patient 139, normal, homogenized [OPG study]4.8734337
GSM549110patient 046, normal, homogenized [OPG study]5.2093744
GSM549114patient 063, normal, homogenized [OPG study]5.0362242
GSM549122patient 082, normal, homogenized [OPG study]4.7644235
GSM549134patient 033, cancer, homogenized [OPG study]5.4188949
GSM549136patient 036, cancer, homogenized [OPG study]6.9699671
GSM549140patient 044, cancer, homogenized [OPG study]5.778255
GSM549111patient 047, normal, homogenized [OPG study]5.309647
GSM549113patient 057, normal, homogenized [OPG study]5.6462253
GSM549132patient 031, cancer, homogenized [OPG study]5.8610356
GSM549137patient 038, cancer, homogenized [OPG study]6.6977468
GSM549142patient 047, cancer, homogenized [OPG study]5.5355848
GSM549100patient 110, normal, homogenized [OPG study]4.6350432
GSM549107patient 135, normal, homogenized [OPG study]5.0460842
GSM549115patient 068, normal, homogenized [OPG study]5.4064549
GSM549116patient 072, normal, homogenized [OPG study]5.199345
GSM549120patient 078, normal, homogenized [OPG study]4.8883538
GSM549131patient 030, cancer, homogenized [OPG study]4.9215840
GSM549118patient 074, normal, homogenized [OPG study]5.3720948
GSM549129patient 027, cancer, homogenized [OPG study]5.9516957
GSM549123patient 088, normal, homogenized [OPG study]5.1061943
GSM549124patient 006, cancer, homogenized [OPG study]6.2299762
GSM549126patient 015, cancer, homogenized [OPG study]6.0267459
GSM549128patient 025, cancer, homogenized [OPG study]6.9778970
GSM549103patient 117, normal, homogenized [OPG study]4.906237
GSM549117patient 073, normal, homogenized [OPG study]4.8795238
GSM549138patient 041, cancer, homogenized [OPG study]5.7752654
GSM549141patient 045, cancer, homogenized [OPG study]6.0980460
GSM549130patient 028, cancer, homogenized [OPG study]5.8271755
GSM549101patient 111, normal, homogenized [OPG study]5.2403144
GSM549105patient 128, normal, homogenized [OPG study]5.1302642
GSM549106patient 134, normal, homogenized [OPG study]6.9433870
GSM549112patient 048, normal, homogenized [OPG study]5.0597842
GSM549125patient 011, cancer, homogenized [OPG study]5.5445950
GSM549127patient 024, cancer, homogenized [OPG study]6.3505762
GSM549135patient 035, cancer, homogenized [OPG study]6.5340765